Health
Continue to drive global industrial innovation to
create a medical-grade, one-stop, all-scenario health ecosystem
Through an open and globally integrated pharmaceutical R&D system with independent R&D, co-development, license-in and industrial investment, Fosun's Health segment focuses on core therapeutic areas, including oncology (solid tumors and hematologic malignancies) as well as immunology and inflammation. Fosun places special emphasis on strengthening core technology platforms for antibodies and antibody drug conjugates (ADC), cell therapies and small molecules, while deploying cutting-edge therapeutic modalities such as radiopharmaceuticals, RNA therapeutics, gene therapies and AI-powered drug R&D through industry funds.
Medical aesthetics, respiratory health, professional medical devices, and medical diagnosis
Focusing on high-quality medical and professional services, the offerings include combined insurance,
health consumption, and wellness solutions, designed to create a comprehensive closed-loop solution
A Core Company In The Health Segment
A global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China
Fosun Pharma directly operates businesses including pharmaceuticals, medical devices, medical diagnosis, and healthcare services.
As a shareholder of Sinopharm Co., Ltd., Fosun Pharma expands its areas in the pharmaceutical distribution and retail business.
-
41.662RMB billion
Operating revenue in 2025
-
9.893RMB billion
Revenue from innovative drugs
-
5.913RMB billion
R&D investment in 2025
-
Pharmaceuticals
Innovative drugs
Mature products and manufacturing
Vaccine -
Medical Devices and Medical Diagnosis
Medical devices
Medical diagnosis -
Healthcare Services
Online medical service platform
Offline medical institutions
(including rehabilitation medical institutions)


















